Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00214591
Status:
TERMINATED
Last Update Posted:
2010-11-19
First Post:
2005-09-20
Brief Title:
GALLANT 5 Tesaglitazar Versus Metformin
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Diabetes Mellitus Type 2 |
Keywords:
| Name | View |
|---|---|
| Type 2 diabetes | View |